If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Humalog®
Humalog® U-100 (insulin lispro injection)
100 units/mLHumalog® U-200 (insulin lispro injection)
200 units/mLHumalog® MIX50/50™ (50% insulin lispro protamine suspension 50% insulin lispro injection [rDNA origin])
100 units/mLHumalog® MIX75/25™ (75% insulin lispro protamine suspension 25% insulin lispro injection [rDNA origin])
100 units/mLThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Do NOT administer IL-200 using an insulin pump, CSII.1
Administering IL-200 via CSII is not recommended because
this may result in overdose and severe hypoglycemia (low blood glucose)
IL-200 is only available in a Pen, and
Enclosed Prescribing Information
HUMALOG® (insulin lispro injection [rDNA origin]), Lilly
1. Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
Glossary
CSII = continuous subcutaneous insulin infusion
IL-200 = Humalog® (insulin lispro injection) 200 units/mL
Pen = KwikPen®
Date of Last Review: December 06, 2019
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST